TVTX · Travere Therapeutics, Inc. · Share Buybacks

$50.85 -0.04 (-0.07%) At close · Oct 28 Q2 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$4.73B

94.26M

Volume · Oct 28 1.57M Avg daily vol (3M) 1.78M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established	Last Amended	Capacity	Sold	Remaining	Runs Through	Source
2024-10	—	$100,000,000	—	—	—	10-Q , filed 2026-08-04

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2016-12-31	$0	—	—	10-K, filed 2017-03-01
2015-12-31	$0	—	—	10-K, filed 2017-03-01
2014-12-31	$2,257,000	—	—	10-K, filed 2017-03-01
2013-12-31	$958,000	130,790	$7.32	10-K, filed 2016-02-26

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2014-12-31	$0 Δ	—	—	10-K, filed 2017-03-01
2014-09-30	$0 Δ	—	—	10-Q, filed 2015-11-06
2014-03-31	$2,257,336	—	—	10-Q, filed 2015-05-11

Key facts CIK 1438533 CUSIP 89422G107 13F (30d) 53 filings 50 filers Visit website Investor relations